Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
COVID-19
.
Show all posts
Showing posts with label
COVID-19
.
Show all posts
Friday, October 30, 2026
FDA Approves Xocova (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure
›
In continuation of my update on ensitrelvir Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, P...
Wednesday, September 30, 2026
Ensitrelvir cuts household COVID-19 risk when given after exposure
›
Ensitrelvir COVID-19 Prevention Background The coronavirus disease 2019 ( COVID-19 ) pandemic caused millions of deaths worldwide. Although ...
Thursday, April 2, 2026
FDA Accepts Shionogi’s Ensitrelvir NDA for Review as the First Oral Therapy for the Prevention of COVID-19 Following Exposure
›
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced the U.S...
Saturday, January 23, 2021
Researchers identify three drugs as possible therapeutics for COVID-19
›
In continuation of my update on Amodiaquine and nebivolol amodiaquine Zuclopenthixol Nebivolol Based on virtual and in vitro antiviral scre...
›
Home
View web version
